TrialReader


Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye

NCT02236364 — Terminated, 25 participants, University of Toledo Health Science Campus

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Blood Glucose Monitoring Based on Imaging of the Eye

RegistryNCT02236364
StatusTerminated - The study was pulled by the sponsor due to lack of funding.
Study typeObservational
Enrollment25 (Actual)
SponsorUniversity of Toledo Health Science Campus (Other); collaborators: University of Toledo
ConditionsDiabetes
InterventionsPhotographic Image Capture System (Device)
Datesstart 2014-08-01, primary completion 2015-05-01, completion 2015-05-01, first posted 2014-09-10, last updated 2025-08-13
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Diabetes All trials of Photographic Image Capture System

-Summary

Previous animal studies done by Dr. Brent Cameron in 2013 at the Univ. of Toledo have shown that glucose present in the fluid in the front of the eye, called the aqueous humor, correlates well with blood glucose. As blood glucose changes, the optical properties of the aqueous humor change, causing a change in the appearance of the iris of the eye.. The data collected in this study will be shared with IRISense to assist in validating the algorithm being used to develop the database needed. The data collected so far is in a narrow band of the normal glycemic range (healthy volunteers). We will collect standard digital photographic images of the eyes of subjects with diabetes along with corresponding blood glucose concentrations using the finger stick glucose monitoring method. In order to do this we will use standard digital photography techniques that is embedded in our benchtop prototype device

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Participants with type 1 or type 2 diabetesDevice: Photographic Image Capture SystemParticipants with type 1 or type 2 diabetes will have images of their iris collected at the same time as a fingerstick blood sugar
  • Photographic Image Capture System (Device): Collection of images of the iris along with corresponding fingerstick blood glucose

+Outcome measures

Primary outcomes

  • Data Acquisition for Continued Algorithm Development Using Photographic Images of the Iris Compared to Fingerstick Glucose Concentration [60 day period]: Eight digital photographic image of the subject's iris will be obtained at various times during each visit under standard illumination using the developed instrumentation. A point-of-care fingerstick blood glucose reading will be taken with an FDA approved blood glucose measurement device (i.e., Contour, Bayer Healthcare, LLC) as close to simultaneously as possible with the photograph.

+Eligibility

Sex: All, ages: 18 Years to 75 Years

Inclusion Criteria:

* Diagnosis of Diabetes Type 1 and 2 and can be verified by the principal investigator

Exclusion Criteria:

* Patients with any disease or abnormality of the eye
* Patients who are mentally incapacitated, cognitively impaired or with severe psychological disorders and cannot sign consent on their own

+Posted results

Participant flow

MilestoneNew Device for OPTICAL Determination of Blood Glucose Level
Started25
Completed0
Not completed25

Outcome results

  • Data Acquisition for Continued Algorithm Development Using Photographic Images of the Iris Compared to Fingerstick Glucose Concentration (Primary)

Adverse events

ArmDeathsSerious adverse eventsOther adverse events
New Device for OPTICAL Determination of Blood Glucose Level0/25 (0.0%)0/25 (0.0%)0/25 (0.0%)

+Locations (1)

FacilityCityCountryStatus
University of Toledo, Health Science CampusToledo, OhioUnited States

My Notes